SATELLITE SESSIONS
Thursday, 16th September 2004
|
TIME |
PHARMACEUTICAL COMPANY |
SESSION TITLE |
HALL |
DETAILS |
|
8:30 a.m. -10:00 a.m. |
MERCK |
Beta-adrenolytic drugs - the basis of cardiovascular treatment |
Boguslawski Hall (The National Theatre) |
YES |
|
10:30 a.m. -12:00 p.m. |
FOURNIER |
Practical therapeutical problems in hypertensive patients |
Ground Floor (Sofitel-Victoria Hotel) |
YES |
|
12:30 p.m. - 2:00 p.m. |
POLPHARMA |
Population research studies of the 21st century |
Boguslawski Hall |
YES |
|
12:30 p.m. - 2:00 p.m. |
NOVARTIS | Global risk factors for cardiovascular disease |
Ground Floor (Sofitel-Victoria Hotel) |
YES |
|
12:30 p.m. - 2:00 p.m. |
ROCHE |
Are beta-blockers a cure-all? |
Hall II (Europejski Hotel) |
YES |
|
2:15 p.m. - 3:45 p.m. |
SERVIER |
Secondary prevention in coronary heart disease - beyond blood pressure control |
Boguslawski Hall |
YES |
Friday, 17th September 2004
| TIME | PHARMACEUTICAL COMPANY |
SESSION TITLE |
HALL | DETAILS |
|
8:30 a.m. -10:00 a.m. |
PFIZER |
"The story of Jan S." From hypertension to cardiovascular complications - diagnostic and therapeutic strategy |
Boguslawski Hall |
YES |
|
8:30 a.m. -10:00 a.m. |
AVENTIS |
According to a new trend: therapeutic approach to acute coronary syndromes in the era of SYNERGY |
Ground Floor |
YES |
|
10:30 a.m. -12:00 p.m. |
POLPHARMA |
Cardiac 2ABS - which drugs can reduce total mortality? |
Boguslawski Hall (The National Theatre) |
YES |
|
10:30 a.m. -12:00 p.m. |
FOURNIER |
Metabolic syndrome - insidious vascular enemy - conclusions for practitioners |
Ground Floor |
YES |
|
12:15 p.m. - 1:45 p.m. |
SCHWARZ PHARMA |
Results of large trials and clinical practice - how do I treat my patients? |
Ground Floor |
YES |
|
12:30 p.m. - 2:00 p.m. |
PFIZER |
How effectively and fast can we protect the patients at high cardiovascular risk? - management strategies |
Boguslawski Hall |
YES |
|
2:30 p.m. - 4:00 p.m. |
BOEHRINGER INGELHEIM |
Fast reperfusion in the treatment of acute myocardial infarction - new perspective |
Boguslawski Hall |
YES |
|
3:00 p.m. - 4:30 p.m. |
SANOFI-SYNTHELABO |
Beta-blockers in cardiovascular disease - facts and controversies |
Ground Floor |
YES |
|
5:00 p.m. - 6:30 p.m. |
SERVIER |
How to treat CAD patients more effectively? |
Boguslawski Hall |
YES |
|
5:00 p.m. - 6:30 p.m. |
ABBOTT |
Cardionephrology - optimum pharmacotherapy 2004 |
Ground Floor |
YES |
Saturday, 18th September 2004
|
TIME |
PHARMACEUTICAL COMPANY |
SESSION TITLE |
HALL | DETAILS |
|
9:30 a.m. -11:00 a.m. |
SERVIER |
Arterial hypertension - Pandora's box of our time |
Boguslawski Hall |
YES |
|
9:30 a.m. -11:00 a.m. |
SANOFI SYNTHELABO |
Debate: Ischaemic events pevention in atherothrombosis. From guidelines to clinical practice |
Ground Floor (Sofitel-Victoria Hotel) |
YES |
|
11:30 a.m. - 1:00 p.m. |
MSD |
Management of high risk cardiovascular patients - guidelines and problems of everyday practice |
Ground Floor (Sofitel-Victoria Hotel) |
YES |